Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
CMN-005 by CoImmune for Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue or MALT-Lymphoma): Likelihood of Approval
CMN-005 is under clinical development by CoImmune and currently in Phase II for Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid...
CMN-005 by CoImmune for Nodal Marginal Zone B-Cell Lymphoma: Likelihood of Approval
CMN-005 is under clinical development by CoImmune and currently in Phase II for Nodal Marginal Zone B-Cell Lymphoma. According to...
CMN-005 by CoImmune for Primary Mediastinal B-Cell Lymphoma: Likelihood of Approval
CMN-005 is under clinical development by CoImmune and currently in Phase II for Primary Mediastinal B-Cell Lymphoma. According to GlobalData,...
CMN-005 by CoImmune for Refractory Chronic Lymphocytic Leukemia (CLL): Likelihood of Approval
CMN-005 is under clinical development by CoImmune and currently in Phase II for Refractory Chronic Lymphocytic Leukemia (CLL). According to...
CMN-005 by CoImmune for Relapsed Chronic Lymphocytic Leukemia (CLL): Likelihood of Approval
CMN-005 is under clinical development by CoImmune and currently in Phase II for Relapsed Chronic Lymphocytic Leukemia (CLL). According to...
CMN-005 by CoImmune for B-Cell Non-Hodgkin Lymphoma: Likelihood of Approval
CMN-005 is under clinical development by CoImmune and currently in Phase II for B-Cell Non-Hodgkin Lymphoma. According to GlobalData, Phase...
CMN-005 by CoImmune for Follicular Lymphoma: Likelihood of Approval
CMN-005 is under clinical development by CoImmune and currently in Phase II for Follicular Lymphoma. According to GlobalData, Phase II...
CMN-005 by CoImmune for Mantle Cell Lymphoma: Likelihood of Approval
CMN-005 is under clinical development by CoImmune and currently in Phase II for Mantle Cell Lymphoma. According to GlobalData, Phase...
CMN-005 by CoImmune for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia): Likelihood of Approval
CMN-005 is under clinical development by CoImmune and currently in Phase II for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic...